Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading update

27 Jun 2022 07:00

RNS Number : 2115Q
PZ CUSSONS PLC
27 June 2022
 

27 June 2022

 

Trading update

 

Continued strategic progress and performance in line with expectations

 

PZ Cussons plc today issues a trading update for the year ended 31 May 2022.

 

Trading in the fourth quarter has continued to be in line with expectations. As such, we anticipate reporting Group revenue for the year of approximately £590 million, with full year like for like (LFL) revenue growth of 3% and Q4 LFL growth of 7%. Growth continues to be driven primarily by improvements in price/mix, with limited impact on volumes. Our expectations for FY22 Adjusted Profit Before Tax are unchanged.

 

We continue to see good revenue momentum on our Must Win Brands, which grew 4% in Q4. This sequential improvement reflects the ongoing benefit of marketing and executional focus, a normalising of the supply challenges for US Beauty, and a significantly lower rate of decline in Carex, as the demand for the Hand Hygiene category in the UK normalises following the COVID pandemic.

 

Childs Farm, which was acquired in March, has performed in line with expectations and our plans to develop the brand are progressing well.

 

Jonathan Myers, Chief Executive Officer, said:

 

"As we close our first full financial year under our new strategy, 'Building brands for life. Today and for future generations', I am pleased with the significant progress made in returning the business to sustainable, profitable revenue growth. With a new team in place, we have re-focused on the core job of building brands and have started to unlock value through dramatically reducing complexity in our business.

 

The trading environment continues to be challenging, with high input cost inflation and pressures on household budgets. We have plans in place to mitigate the impact of this, as we continue to deliver great value for consumers, whilst also investing behind more premium innovations. The recent introduction of our new portfolio brand, Cussons Creations, for the value-conscious consumer, alongside the re-launches of Sanctuary Spa and Imperial Leather, are good examples of such initiatives. They have been well received by customers and have allowed us to secure significant distribution gains.

We have great brands and great people and, whilst there is more to be done to deliver against our strategy, we remain excited by the long-term opportunities ahead of us."

 

PZ Cussons will report FY22 results and provide a FY23 outlook, along with its Q1 trading update, on 22nd September.

 

Contact details

 

Investors

Simon Whittington - IR and Corporate Development Director

+44 (0) 7711 372 928

Media

Tim Linacre / Guy Scarborough - Instinctif

+44 (0) 20 7457 2020

 

Notes to Editors

 

Unless otherwise stated, all references to revenue growth are on a like for like ('LFL') basis which adjusts for constant currency and excludes the impact of disposals (five:am) and acquisitions (Childs Farm).

 

Figures are unaudited and are still subject to review by the Group's auditors.

 

About PZ Cussons

 

PZ Cussons is a FTSE250 listed consumer goods business, headquartered in Manchester, UK. We employ over 3,000 people across our operations in Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. Across our core categories of Hygiene, Baby and Beauty, our trusted and well-loved brands include Carex, Imperial Leather, Original Source, Cussons Baby, Sanctuary Spa, St.Tropez, Morning Fresh and Premier. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy, and captured by our purpose: For everyone, for life, for good.

 

 

Cautionary note regarding forward-looking statements

 

This announcement contains certain forward-looking statements relating to expected or anticipated results, performance or events. Such statements are subject to normal risks associated with the uncertainties in our business, supply chain and consumer demand along with risks associated with macro-economic, political and social factors in the markets in which we operate. Whilst we believe that the expectations reflected herein are reasonable based on the information we have as at the date of this announcement, actual outcomes may vary significantly owing to factors outside the control of the Group, such as cost of materials or demand for our products, or within our control such as our investment decisions, allocation of resources or changes to our plans or strategy. The Group expressly disclaims any obligation to revise forward-looking statements made in this or other announcements to reflect changes in our expectations or circumstances. No reliance may be placed on the forward looking statements contained within this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUQWQUPPPPQ
Date   Source Headline
20th May 20264:49 pmRNSDirector/PDMR Shareholding
21st Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20268:43 amRNSDirector/PDMR Shareholding
10th Apr 20264:01 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSQ3 TRADING UPDATE
19th Mar 20268:59 amRNSDirector/PDMR Shareholding
3rd Mar 20264:27 pmRNSDirector/PDMR Shareholding
19th Feb 202611:04 amRNSDirector/PDMR Shareholding
13th Feb 20263:32 pmRNSDirector/PDMR Shareholding
13th Feb 20262:21 pmRNSDirector/PDMR Shareholding
11th Feb 20267:01 amRNSCapital Markets Event
11th Feb 20267:00 amRNSInterim Results
22nd Jan 20263:00 pmRNSDirectorate change
20th Jan 20264:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirectorate change
22nd Dec 20257:00 amRNSDirectorate change
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
15th Dec 20254:27 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSConclusion of Strategic Review of Africa
2nd Dec 20252:42 pmRNSDirector/PDMR Shareholding
28th Nov 20253:25 pmRNSDirector/PDMR Shareholding
20th Nov 20254:23 pmRNSResult of AGM
20th Nov 20257:00 amRNSAGM Trading Statement
19th Nov 20255:57 pmRNSDirector/PDMR Shareholding
21st Oct 20255:07 pmRNSDirector/PDMR Shareholding
1st Oct 20254:20 pmRNSDirector/PDMR Shareholding
1st Oct 20254:16 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSDirectorate Change
25th Sep 202512:06 pmRNSPublication of Annual Report and Notice of AGM
24th Sep 20253:56 pmRNSDirector/PDMR Shareholding
19th Sep 20255:03 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSFinal Results
20th Aug 20259:16 amRNSDirector/PDMR Shareholding
21st Jul 20255:07 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSUpdate on St. Tropez
19th Jun 20254:47 pmRNSDirector/PDMR Shareholding
18th Jun 20257:00 amRNSSale of Joint Venture and Trading Update
21st May 20254:49 pmRNSDirector/PDMR Shareholding
7th May 20253:29 pmRNSDirector Declaration
23rd Apr 20254:32 pmRNSDirector/PDMR Shareholding
10th Apr 20255:06 pmRNSDirector/PDMR Shareholding
19th Mar 20254:37 pmRNSDirector/PDMR Shareholding
19th Feb 202511:38 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSInterim Results
21st Jan 202511:43 amRNSDirector/PDMR Shareholding
19th Dec 20244:24 pmRNSDirector/PDMR Shareholding
6th Dec 20243:42 pmRNSDirector/PDMR Shareholding
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.